Near-Infrared Optogenetic Nanosystem for Spatiotemporal Control of CRISPR-Cas9 Gene Editing and Synergistic Photodynamic Therapy
ACS Applied Materials & Interfaces · 2025-01-08 · 17 (1) · 701-710
DOI: 10.1021/acsami.4c18656 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2024-12-16. Written by Junyi Zeng and 8 co-authors. Institution: Key Laboratory of Biorheological Science and Technology, Ministry of Education and Bioengineering College, Chongqing University, Chongqing 400044, Ch…. Major MEDLINE topics: Photochemotherapy, Gene Editing, CRISPR-Cas Systems, Infrared Rays. Cited 21 times so far (Crossref); 48 references. Funded by: National Fund for Fostering Talents of Basic Science, Basic and Applied Basic Research Foundation of Guangdong Province, Sanming Project of Medicine in Shenzen Municipality.
Abstract (original language)
Controlling CRISPR/Cas9 gene editing at the spatiotemporal resolution level, especially for in vivo applications, remains a great challenge. Here, we developed a near-infrared (NIR) light-activated nanophotonic system (UCPP) for controlled CRISPR-Cas9 gene editing and synergistic photodynamic therapy (PDT). Lanthanide-doped upconversion nanoparticles are not only employed as carriers for intracellular plasmid delivery but also serve as the nanotransducers to convert NIR light (980 nm) into visible light with emission at 460 and 650 nm, which could result in simultaneous activation of gene editing and PDT processes, respectively. Such unique design not only achieves light-controlled precise gene editing of hypoxia-inducible factor 1α with minimal off-target effect, which effectively ameliorates the hypoxic state at tumor sites, but also facilitates the deep-seated PDT process with synergistic antitumor effect. This optogenetically activatable CRISPR-Cas9 nanosystem holds great potential for spatially controlled in vivo gene editing and targeted cancer therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Biorheological Science and Technology, Ministry of Education and Bioengineering College, Chongqing University, Chongqing 400044, China.
- Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen 518036, China.
- Department of Dermatology, Institute of Dermatology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.
- DEYUE Skin Dermatology Clinic, Shenzhen 518036, China.
Funding
- National Fund for Fostering Talents of Basic Science
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzen Municipality
- Shenzhen Science and Technology Innovation Program
- Scientific Research Foundation of Peking University Shenzhen Hospital
- Shenzhen Key Medical Discipline Construction Fund
Cite
APA
Zeng, J., Huang, X., Yang, Y., Wang, J., Shi, Y., Li, H., Hu, N., Yu, B., & Mu, J. (2025). Near-Infrared Optogenetic Nanosystem for Spatiotemporal Control of CRISPR-Cas9 Gene Editing and Synergistic Photodynamic Therapy. ACS Applied Materials & Interfaces, 17(1), 701-710. https://doi.org/10.1021/acsami.4c18656
Vancouver
Zeng J, Huang X, Yang Y, Wang J, Shi Y, Li H, et al. Near-Infrared Optogenetic Nanosystem for Spatiotemporal Control of CRISPR-Cas9 Gene Editing and Synergistic Photodynamic Therapy. ACS Applied Materials & Interfaces. 2025;17(1):701-710. doi:10.1021/acsami.4c18656
BibTeX
@article{Zeng2025,
author = {Zeng, Junyi and Huang, Xinbo and Yang, Yajie and Wang, Jieyi and Shi, Yuanchao and Li, Hui and Hu, Ning and Yu, Bo and Mu, Jing},
title = {Near-Infrared Optogenetic Nanosystem for Spatiotemporal Control of CRISPR-Cas9 Gene Editing and Synergistic Photodynamic Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {1},
pages = {701--710},
doi = {10.1021/acsami.4c18656}
}
EUVIMED